We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
TRIM5α Variations Influence Transduction Efficiency With Lentiviral Vectors in Both Human and Rhesus CD34<sup>+</sup> Cells In Vitro and In Vivo.
- Authors
Evans, Molly E; Kumkhaek, Chutima; Hsieh, Matthew M; Donahue, Robert E; Tisdale, John F; Uchida, Naoya
- Abstract
Human immunodeficiency virus type 1 (HIV-1) vectors can transduce human hematopoietic stem cells (HSC), but transduction efficiency varies among individuals. The innate immune factor tripartite motif-containing protein 5α (TRIM5α) plays an important role for restriction of retroviral infection. In this study, we examined whether TRIM5α could account for variations in transduction efficiency using both an established rhesus gene therapy model and human CD34+ cell culture. Evaluation of TRIM5α genotypes (Mamu-1, -2, -3, -4, -5, and TrimCyp) in 16 rhesus macaques that were transplanted with transduced CD34+ cells showed a significant correlation between TRIM5α Mamu-4 and high gene marking in both lymphocytes and granulocytes 6 months after transplantation. Since significant human TRIM5α coding polymorphisms were not known, we evaluated TRIM5α expression levels in human CD34+ cells from 14 donors. Three days after HIV-1 vector transduction, measured transduction efficiency varied significantly among donors and was negatively correlated with TRIM5α expression levels. In summary, transduction efficiency in both rhesus and human CD34+ cells was influenced by TRIM5α variations (genotypes and expression levels). Our findings are important for both understanding and mitigating the variability of transduction efficiency for rhesus and human CD34+ cells.
- Subjects
HIV-positive persons; GENETIC transduction; TRIM proteins; CD34 antigen; HEMATOPOIETIC stem cell transplantation; VIRUSES
- Publication
Molecular Therapy, 2014, Vol 22, Issue 2, p348
- ISSN
1525-0016
- Publication type
Article
- DOI
10.1038/mt.2013.256